Epicore BioNetworks IncTSXV: EBN

Epicore BioNetworks Inc. Announces New Board Director

· Issued by Epicore BioNetworks Inc via CNW

CALGARY, March 20 /CNW/ - The Board of Directors of Epicore BioNetworks Inc. is pleased to announce a new director has joined the board, effective March 19, 2007. The Board welcomes Mr. Fred N. Boulos of Beaconsfield, Quebec, Canada.

Mr. Boulos has over thirty three years business experience in operations management of Canadian and international companies. His experience includes engineering and construction of oil exploration and pipeline systems and many other interesting projects. He has had contract management and procurement responsibility for multi-million dollar projects. Much of his work experience is in the Middle East and Africa region, which is growing in importance to aquaculture suppliers. Mr. Boulos holds degrees in engineering, marketing and investment analysis. The Board expects that his knowledge and experience will be of great benefit to Epicore.

The Board of Directors has approved issuance to Mr. Boulos of 150,000 options to buy Epicore common shares, pursuant to the terms of the Company's stock option program. The shares will be priced at Cdn $0.125 per share.

Epicore BioNetworks Inc. is a leading producer of environmental biotechnology and animal nutrition products. It manufactures in the USA and markets worldwide to a variety of industries to reduce environmental pollution and increase operational productivity.

Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange (symbol EBN). (The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.)

This press release contains forward-looking statements that involve significant risks and uncertainties. The actual results, performance or achievements of the Company might differ materially from the results, performance or achievements of the Company expressed or implied by such forward-looking statements. Such forward-looking statements include, without limitation, those regarding the development plans of the Company and the expected timing and results of such development. We can provide no assurance that such development will proceed as currently anticipated or that the expected timing or results of such development will be realized. We are subject to various risks, including the uncertainties of product development, markets for our products and regulatory review, our need for additional capital to fund our operations, our reliance on collaborative partners, our history of losses, and other risks inherent in the biotechnology industry.

Epicore BioNetworks Inc on 6ix

Story so far

Earlier from Epicore BioNetworks

Later from Epicore BioNetworks

All Epicore BioNetworks news releases